10X Genomics

10X Genomics

Verified
Building tools for scientific discovery that reveal and address the true complexities of biology and disease

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues---224m272m449m559m
% growth----22 %65 %24 %
EBITDA---(20.9m)(473m)(24.5m)(71.8m)
% EBITDA margin---(9 %)(174 %)(5 %)(13 %)
Profit---(28.2m)(494m)(41.8m)(79.1m)
% profit margin---(13 %)(182 %)(9 %)(14 %)
EV / revenue---28.2x48.8x33.9x13.4x
EV / EBITDA----295.0x-28.0x--104.0x
R&D budget---74m---
R&D % of revenue---33 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
N/A$3mSeries A
N/A$22.4mSeries A
Not yet verified
$55.5mSeries B
$55mSeries C
$50mSeries D
$75mDebt
*
$35m
Valuation: $1.3b
Late VC
N/A$390m
Valuation: $3.7b
IPO
Total Funding$199m

Recent News about 10X Genomics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by 10X Genomics

Edit
EPINOMICS
ACQUISITION by 10X Genomics Aug 2018
ReadCoor
ACQUISITION by 10X Genomics Oct 2020
Spatial Transcriptomics
ACQUISITION by 10X Genomics Dec 2018
CARTANA
ACQUISITION by 10X Genomics Oct 2020